Selected article for: "heart failure patient and pneumonia heart failure"

Author: Zhu, Z.; Tang, J.; Chai, X.; Fang, Z.; Liu, Q.; Hu, X.; Xu, D.; He, J.; Tang, L.; Tai, S.; Wu, Y.; Zhou, S.
Title: How to differentiate COVID-19 pneumonia from heart failure with computed tomography at initial medical contact during epidemic period
  • Cord-id: 4ep7nf3q
  • Document date: 2020_3_6
  • ID: 4ep7nf3q
    Snippet: OBJECTIVES To compare chest CT findings in heart failure with those of Corona Virus Disease 2019 (COVID-19) pneumonia. BACKGROUND During epidemic period, chest computed tomography (CT) has been highly recommended for screening patients with suspected COVID-19. However, the comparison of CT imaging between heart failure and COVID-19 pneumonia has not been fully elucidated. METHODS Patients with heart failure (n=12), COVID-19 pneumonia (n=12) and one patient with both diseases were retrospectively
    Document: OBJECTIVES To compare chest CT findings in heart failure with those of Corona Virus Disease 2019 (COVID-19) pneumonia. BACKGROUND During epidemic period, chest computed tomography (CT) has been highly recommended for screening patients with suspected COVID-19. However, the comparison of CT imaging between heart failure and COVID-19 pneumonia has not been fully elucidated. METHODS Patients with heart failure (n=12), COVID-19 pneumonia (n=12) and one patient with both diseases were retrospectively enrolled. Clinical information and imaging of chest CT were collected and analyzed. RESULTS There was no difference of ground glass opacity (GGO), consolidation, crazy paving pattern, lobes affected and septal thickening between heart failure and COVID-19 pneumonia. However, less rounded morphology (8.3% vs. 67%, p=0.003), more peribronchovascular thickening (75% vs. 33%, p=0.041) and fissural thickening (33% vs. 0%, p=0.028), less peripheral distribution (33% vs. 92%, p=0.003) were found in heart failure group than that in COVID-19 group. Importantly, there were also more patients with upper pulmonary vein enlargement (75% vs. 8.3%, p=0.001), subpleural effusion and cardiac enlargement in heart failure group than that in COVID-19 group (50% vs. 0%, p=0.005, separately). Besides, more fibrous lesions were found in COVID-19 group although there was no statistical difference (25% vs. 0%, P=0.064) CONCLUSIONS Although there are some overlaps of CT imaging between heart failure and COVID-19, CT is still a useful tool in differentiating COVID-19 pneumonia.

    Search related documents:
    Co phrase search for related documents
    • absence presence and lobes involvement: 1, 2
    • absence presence and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • absence presence and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and lymphocyte count: 1, 2, 3, 4, 5, 6
    • absence presence and lymphocyte ratio: 1, 2, 3
    • acute myocardial infarction and lung disease: 1, 2, 3
    • acute myocardial infarction and lung tissue: 1, 2
    • acute myocardial infarction and lymphocyte count: 1, 2
    • acute myocardial infarction and lymphocyte ratio: 1, 2, 3, 4, 5, 6
    • acute myocardial infarction and lymphocyte ratio relative decrease: 1
    • acute myocardial infarction and lymphocyte ratio relative decrease cause: 1
    • acute myocardial infarction heart failure and lymphocyte count: 1
    • acute myocardial infarction heart failure and lymphocyte ratio: 1, 2
    • acute myocardial infarction heart failure and lymphocyte ratio relative decrease: 1
    • acute myocardial infarction heart failure and lymphocyte ratio relative decrease cause: 1
    • lobes involvement and lung disease: 1, 2, 3, 4, 5, 6, 7, 8
    • lobes involvement and lung tissue: 1
    • lobes involvement and lymphocyte count: 1, 2, 3, 4
    • lobes involvement and lymphocyte ratio: 1